Back to search
FDAFDA · Food and drugs·Recall number Z-2305-2019

BD Vacutainer PST Gel and Lithium HeparinN (LH) 126 Units Blood Collection Tubes, Catalog Number 367964

Published August 28, 2019 · Recall initiated: June 12, 2019

Summary

FDA records medical device Class II recall Z-2305-2019, published August 28, 2019 and initiated June 12, 2019. Recalling firm: Becton Dickinson & Company; Status: Terminated; Reported quantity: 1,436,228,004 total; Lot: UDI: (01)30382903679646. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

False elevation of carboxyhemoglobin (COHb) results have been reported when using venous blood gas samples collected with tubes analyzed with the IL GEM 4000 instrument.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Becton Dickinson & Company
Distributor
Worldwide Distribution, including US Nationwide
Lot
UDI: (01)30382903679646
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BD Vacutainer PST Gel and Lithium HeparinN (LH) 126 Units Blood Collection Tubes, Catalog Number 367964 recalled?

Yes. FDA published recall Z-2305-2019 on August 28, 2019. Reported hazard: False elevation of carboxyhemoglobin (COHb) results have been reported when using venous blood gas samples collected with tubes analyzed with the IL GEM 4000 instrument.

What should I do if I have this product?

Voluntary: Firm initiated · Letter